Cite
APA Citation
Devillier, R., Bertoli, S., Prébet, T., Huguet, F., Etienne, A., Charbonnier, A., Rey, J., Delabesse, E., D'Incan, E., Huynh, A., Blaise, D., Récher, C., & Vey, N. (n.d.). comparison of 60 or 90 mg/m2 of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics. American journal of hematology, 90(2), E29–E30. http://access.bl.uk/ark:/81055/vdc_100025106909.0x000017